A Decade of Reduced-Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Following Conditioning with Fludarabine, Busulphan and Alemtuzumab

被引：0
|
作者：
Ho, Aloysius Y. L. [1 ]
Krishnamurthy, Pramila [2 ]
Lim, ZiYi [2 ]
Kenyon, Michelle [2 ]
Mijovic, Aleksander [1 ]
Devereux, Stephen
Pagliuca, Antonio
Mufti, Ghulam J. [2 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England
[2] Kings Coll Hosp London, Dept Haematol Med, London, England
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：893 / 893
页数：1
相关论文
共 50 条
  • [1] Reduced-intensity allogeneic haematopoietic stem cell transplantation(HSCT) in 75 patients with myelodysplastic syndromes following conditioning with fludarabine, busulphan and alemtuzumab.
    Ho, AYL
    Kenyon, M
    El-Hemaidi, I
    Mijovic, A
    Devereux, S
    Pagliuca, A
    Mufti, GJ
    [J]. BLOOD, 2003, 102 (11) : 78A - 78A
  • [2] Reduced-intensity allogeneic haematopoietic stem cell transplantation for poor prognosis myelodysplastic syndromes using fludarabine, busulphan and CAMPATH-1H (alemtuzumab) conditioning.
    Ho, AYL
    El-Hemaidi, I
    Kenyon, M
    Pagliuca, A
    Devereux, S
    Mufti, G
    [J]. BLOOD, 2002, 100 (11) : 621A - 621A
  • [3] Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning
    Ho, AYL
    Pagliuca, A
    Kenyon, M
    Parker, JE
    Mijovic, A
    Devereux, S
    Mufti, GJ
    [J]. BLOOD, 2004, 104 (06) : 1616 - 1623
  • [4] Reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation with or without alemtuzumab in acute myelogenous leukaemia and myelodysplastic syndromes:: comparison between two prospective studies using fludarabine and oral busulphan
    Martino, R
    Ho, A
    Sierra, J
    Caballero, MD
    Pérez-Simón, JA
    Pagliuca, A
    Devereux, S
    Kenyon, M
    Besalduch, J
    Urbano-Ispizua, A
    Sanz, G
    Solano, C
    Moraleda, JM
    Mufti, G
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S11 - S12
  • [5] REDUCED-INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Kuzmina, Larisa A.
    Parovichnikova, Elena N.
    Sorokina, Tamara V.
    Petinati, Natalia A.
    Drokov, Michail Y.
    Savchenko, Valeriy G.
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 : S18 - S19
  • [6] Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study
    Aoki, Kazunari
    Ishikawa, Takayuki
    Ishiyama, Ken
    Aoki, Jun
    Itonaga, Hidehiro
    Fukuda, Takahiro
    Kakihana, Kazuhiko
    Uchida, Naoyuki
    Ueda, Yasunori
    Eto, Tetsuya
    Mori, Takehiko
    Kondo, Tadakazu
    Iwato, Koji
    Morishima, Yasuo
    Tanaka, Junji
    Atsuta, Yoshiko
    Miyazaki, Yasushi
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (03) : 463 - 466
  • [7] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [8] Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Nagi, W.
    Lim, Z. Y.
    Krishnamurthy, P.
    Potter, V.
    Tindell, V.
    Reiff-Zall, L.
    Abdullah, A.
    Lea, N.
    Kenyon, M.
    Marsh, J.
    Ho, A. Y. L.
    Mufti, G. J.
    Pagliuca, A.
    [J]. LEUKEMIA RESEARCH, 2011, 35 (08) : 998 - 1000
  • [9] Impact of age on outcome of reduced-intensity conditioning with fludarabine and busulfan for allogeneic haematopoietic cell transplantation
    Schneidawind, D.
    Federmann, B.
    Helwig, A.
    Vogel, W.
    Faul, C.
    Kanz, L.
    Bethge, W. A.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S230 - S230
  • [10] ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REDUCED-INTENSITY CONDITIONING IN CHRONIC MYELOID LEUKAEMIA
    Morozova, E., V
    Vlasova, Y., I
    Barabanshikova, M., V
    Afanaseva, K. S.
    Iurovskaia, K. S.
    Gindina, T. L.
    Barchatov, I. M.
    Alyanskiy, A. L.
    Bakin, E. A.
    Bondarenko, S. N.
    Moiseev, I. S.
    Zubarovskaya, L. S.
    Afanasyev, B., V
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (04): : 386 - 402
12345